1. Platforms

    CCGD provides access to cutting-edge technologies such as SNP arrays, next-generation sequencing and mass-spectrometric genotyping of somatic mutations ("OncoMap").

    Learn More
  2. People and Organization

    CCGD is composed of 11 Dana-Farber faculty members, many of whom are associate members of the Broad Institute.

    Learn More
  3. FAQs

    How can I collaborate with CCGD to utilize new technologies to analyze my cancer samples?

    Learn More